Certerra

At FSC, skin-deep startup joins Start-Up NY’s ranks

By GREGORY ZELLER // The Empire State Development Corp. has opened its books and welcomed another Long Island company into the Start-Up NY family. Farmingdale State College announced this week that startup biotech BF Innovation, which moved into FSC’s Broad Hollow Bioscience Park earlier this year, has been accepted into the Start-Up NY program, which boosts new and expanding businesses with tax breaks and innovative academic partnerships. BF Innovation plans to invest $1 million and…


Start-Up NY adds 39, including two LI companies

By GREGORY ZELLER // Thirty-nine early-stage companies, including two on Long Island, have been welcomed into the Start-Up NY program. The companies will either launch in or relocate to “tax-free zones” at or near New York colleges and universities – an ambitious program designed to let entrepreneurs hold onto working capital while simultaneously fostering innovation hubs and bolstering regional economies. The Long Island region will be bolstered by the creation of 26 new jobs, according…


Andrew Whiteley is now executively in residence

By GREGORY ZELLER // It’s become vogue for research institutions to staff “entrepreneurs-in-residence,” experienced innovators who can help science-based startups find their commercial footing, because they’ve been there and done that. Leave it to Cold Spring Harbor Laboratory to give the notion an innovative spin with a first-ever “executive-in-residence,” a 25-year life-sciences and drug-discovery veteran named Andrew Whiteley. In Whiteley, the lab doesn’t really have an entrepreneur – he’s never actually launched a new business himself – but it does…


Discovering a world beyond contract research

By GREGORY ZELLER // Cold Spring Harbor Laboratory spinoff Certerra Inc. is finally getting ready to spin off. Founded in 2011 by CSHL associate professor Pavel Osten and venture capitalist Steve Winick, Certerra screens drugs to test their effectiveness on a broad spectrum of brain-based disorders. Until now, the company has focused on mouse brain scans for pharmaceutical and biotechnology clients, helping them improve predictability before their experimental compounds move on to human clinical trials….